3beta-acetoxy-11-oxo-18beta11-olean-12-en-30-oic acid 3-quinolinyl amide

ID: ALA4865221

PubChem CID: 164623209

Max Phase: Preclinical

Molecular Formula: C41H54N2O4

Molecular Weight: 638.89

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(=O)O[C@H]1CC[C@@]2(C)C(CC[C@]3(C)C2C(=O)C=C2C4C[C@@](C)(C(=O)Nc5cnc6ccccc6c5)CC[C@]4(C)CC[C@]23C)C1(C)C

Standard InChI:  InChI=1S/C41H54N2O4/c1-25(44)47-33-14-15-39(6)32(36(33,2)3)13-16-41(8)34(39)31(45)22-28-29-23-38(5,18-17-37(29,4)19-20-40(28,41)7)35(46)43-27-21-26-11-9-10-12-30(26)42-24-27/h9-12,21-22,24,29,32-34H,13-20,23H2,1-8H3,(H,43,46)/t29?,32?,33-,34?,37+,38-,39-,40+,41+/m0/s1

Standard InChI Key:  XAQVSOGYDHLHGA-FFTJLYNLSA-N

Molfile:  

 
     RDKit          2D

 47 53  0  0  0  0  0  0  0  0999 V2000
    2.7374   -6.3705    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7374   -7.1954    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4494   -7.6038    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4494   -5.9539    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1613   -6.3705    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1624   -7.1954    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8734   -7.6048    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5879   -7.1936    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8713   -5.9549    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5888   -6.3694    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5875   -4.7150    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8675   -5.1285    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3051   -5.1295    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3040   -5.9581    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0171   -6.3710    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7357   -5.9599    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0192   -4.7139    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7363   -5.1361    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4564   -4.7283    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4658   -3.8969    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7488   -3.4747    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0223   -3.8840    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3287   -2.8831    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1580   -2.8831    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1276   -3.0889    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.1074   -2.0885    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.8582   -8.1871    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0289   -8.1871    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1539   -5.5455    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5831   -5.5414    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0236   -7.6089    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.3085   -7.1976    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5969   -7.6111    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3073   -6.3726    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.2997   -6.7830    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7053   -2.4998    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5042   -2.7093    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0640   -1.1202    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.4820   -1.7086    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8634   -1.3281    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0787   -2.1255    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8725   -2.3366    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4566   -1.7534    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2413   -0.9560    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.4418   -0.7417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1526   -4.7168    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.4454   -5.5455    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  4  1  0
  2  3  1  0
  3  6  1  0
  5  4  1  0
  5  6  1  0
  5  9  1  0
  6  7  1  0
  7  8  1  0
  8 10  1  0
  9 10  1  0
  9 12  1  0
 10 14  1  0
 13 11  2  0
 11 12  1  0
 13 14  1  0
 13 17  1  0
 14 15  1  0
 15 16  1  0
 16 18  1  0
 17 18  1  0
 17 22  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 21 23  1  1
 21 24  1  0
 23 25  1  0
 23 26  2  0
  3 27  1  0
  3 28  1  0
  5 29  1  1
 10 30  1  1
  2 31  1  1
 31 32  1  0
 32 33  1  0
 32 34  2  0
 14 35  1  6
 25 36  1  0
 36 37  2  0
 36 39  1  0
 37 41  1  0
 40 38  1  0
 38 39  2  0
 40 41  2  0
 40 45  1  0
 41 42  1  0
 42 43  2  0
 43 44  1  0
 44 45  2  0
 12 46  2  0
 18 47  1  1
M  END

Alternative Forms

  1. Parent:

    ALA4865221

    ---

Associated Targets(Human)

SF-268 (49410 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Zika virus (1028 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 638.89Molecular Weight (Monoisotopic): 638.4084AlogP: 9.09#Rotatable Bonds: 3
Polar Surface Area: 85.36Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 2HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: 13.37CX Basic pKa: 3.63CX LogP: 8.06CX LogD: 8.06
Aromatic Rings: 2Heavy Atoms: 47QED Weighted: 0.34Np Likeness Score: 1.79

References

1. Baltina LA, Lai HC, Liu YC, Huang SH, Hour MJ, Baltina LA, Nugumanov TR, Borisevich SS, Khalilov LM, Petrova SF, Khursan SL, Lin CW..  (2021)  Glycyrrhetinic acid derivatives as Zika virus inhibitors: Synthesis and antiviral activity in vitro.,  41  [PMID:34022526] [10.1016/j.bmc.2021.116204]

Source